Steven Schultz

Steven Schultz headshot

Vice President of Product Development, Allergan

Steven Schultz has extensive experience and a record of success in leading cross-functional teams and delivering highly successful products across a broad range of technologies within the healthcare industry. He has deep expertise in Design for Six Sigma (DFSS), Design for Manufacturability (DFM), product and process development, program management, R&D, manufacturing, materials science, hydrophilic coatings, and polymers for drug-device combination products and medical devices. 

Steve managed the development of the first new crosslinking technology focused on all-natural components, which enabled extensive increases in properties and product differentiations, reduced processing times by 20+%, and increased stability 15%. He led a strategic alignment initiative that drove significant new product ideas into the pipeline and fueled six new high-value product launches in support of the bradycardia, tachycardia, and heart failure business segments. He co-created and led the development and execution of a strategic plan for a struggling Plastics and Regenerative Medicine franchise, which enabled two technology acquisitions and a 30% increase in internal resources. 

Most recently at Allergan, a global pharmaceutical and medical device company, Steve oversaw global product development efforts for devices, including ophthalmology stents, breast implants, dermal fillers, surgical scaffolds, and drug-device combination products. He directed numerous departmental and cultural upgrades, including the formation and implementation of a Core Team model, which drove higher performance. He co-led the creation of short- and long-term strategies for the plastic surgery franchise involving a combination of internal development and strategic tuck-in acquisitions to fuel growth, which led to a 30% increase in product launches over a three-year period. 

Prior to joining Allergan Steve was a Vice President at Medtronic, where he developed a winning strategy and vision for the defibrillator and pacemaker leads product development area, partnering crossfunctionally and across the manufacturing sites to reduce development cost and time-to-market while increasing product quality, leading to stronger overall performance. He also led numerous events designed to obtain voice of customer inputs by establishing and championing multiple animal implant summits. 

Earlier in his career, Steve held a series of leadership positions at Boston Scientific including Vice President R&D and Program Management. He also held engineering positions at W.R. Grace & Co., Shawmut Mills, and Halliburton Services. 

Steve completed his MBA in Technology Management at Northeastern University, in Boston. He also holds a Master of Science degree in Plastics Engineering and a Bachelor of Science in Chemical Engineering from the University of Massachusetts-Lowell in Lowell, MA. He is a member of the Industrial Advisory Board (IAB), Department of Chemical Engineering, University of Massachusetts-Lowell.